Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Dyne Therapeutics Inc., 3 years.
Dyne Therapeutics Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Dyne Therapeutics Inc. June 5, 202687.4%
-
Dyne Therapeutics Inc. May 24, 202367.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 14, 2026 | Dyne Therapeutics Inc. | Open-market sale | −1,359,674 | $25.00 | $33,991,850 |
| Aug 14, 2026 | Dyne Therapeutics Inc. | Open-market sale | −478,377 | $25.00 | $11,959,425 |
| Aug 14, 2026 | Dyne Therapeutics Inc. | Open-market sale | −322,465 | $25.00 | $8,061,625 |
| Aug 13, 2026 | Dyne Therapeutics Inc. | Open-market sale | −268,354 | $26.20 | $7,030,875 |
| Aug 13, 2026 | Dyne Therapeutics Inc. | Open-market sale | −94,415 | $26.20 | $2,473,673 |
| Aug 13, 2026 | Dyne Therapeutics Inc. | Open-market sale | −63,643 | $26.20 | $1,667,447 |
| Jul 7, 2026 | Dyne Therapeutics Inc. | Open-market sale | −124,379 | $23.17 | $2,881,861 |
| Jul 7, 2026 | Dyne Therapeutics Inc. | Open-market sale | −29,587 | $23.62 | $698,845 |
| Jul 7, 2026 | Dyne Therapeutics Inc. | Open-market sale | −62,543 | $23.17 | $1,449,121 |
| Jul 7, 2026 | Dyne Therapeutics Inc. | Open-market sale | −14,844 | $23.62 | $350,615 |
| Jul 7, 2026 | Dyne Therapeutics Inc. | Open-market sale | −49,193 | $23.17 | $1,139,802 |
| Jul 7, 2026 | Dyne Therapeutics Inc. | Open-market sale | −11,665 | $23.62 | $275,527 |
| Jul 7, 2026 | Dyne Therapeutics Inc. | Open-market sale | −5,000 | $23.61 | $118,050 |
| Jul 6, 2026 | Dyne Therapeutics Inc. | Open-market sale | −253,039 | $22.79 | $5,766,759 |
| Jul 6, 2026 | Dyne Therapeutics Inc. | Open-market sale | −127,182 | $22.79 | $2,898,478 |
Questions about Jason P. Rhodes
What boards is Jason P. Rhodes on?
Jason P. Rhodes sits on the board of Dyne Therapeutics Inc.
How long has Jason P. Rhodes served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.